Iovance Biotherapeutics Inc is a company in the U.S. stock market and it is a holding in 54 U.S.-traded ETFs. IOVA has around 13.5M shares in the U.S. ETF market. The largest ETF holder of IOVA is the ARK Innovation ETF (ARKK), with approximately 2.45M shares. Investors may also find of interest that the ETF with the largest allocation to IOVA stock is ARK Genomic Revolution ETF (ARKG), with a portfolio weight of 3.67%. On average, U.S. ETFs allocate 0.41% of IOVA to their portfolios.
Additionally, IOVA is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with IOVA as a holding is the ARK Genomic Revolution ETF (ARKG), with a return of 58.95%.